Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes


Autoria(s): Donaldson, H; McCalmont, M; Livermore, D M; Rooney, P J; Ong, G; McHenry, E; Campbell, R; McMullan, R
Data(s)

01/11/2008

Resumo

A new VITEK 2 antibiotic susceptibility testing (AST) card, AST N-054, was introduced for aerobic gram-negative bacilli in 2007 and has been widely adopted for routine use in the UK. We evaluated its performance for detecting extended-spectrum beta-lactamase (ESBL) production in Escherichia coli.

Identificador

http://pure.qub.ac.uk/portal/en/publications/evaluation-of-the-vitek-2-ast-n054-test-card-for-the-detection-of-extendedspectrum-betalactamase-production-in-escherichia-coli-with-ctxm-phenotypes(1ad02bd7-51c8-4332-8413-9c2240dbb602).html

http://dx.doi.org/10.1093/jac/dkn316

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Donaldson , H , McCalmont , M , Livermore , D M , Rooney , P J , Ong , G , McHenry , E , Campbell , R & McMullan , R 2008 , ' Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes ' Journal of Antimicrobial Chemotherapy , vol 62 , no. 5 , pp. 1015-7 . DOI: 10.1093/jac/dkn316

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology #/dk/atira/pure/subjectarea/asjc/2700/2736 #Pharmacology (medical) #/dk/atira/pure/subjectarea/asjc/2700/2725 #Infectious Diseases
Tipo

article